News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
294,970 Results
Type
Article (10087)
Company Profile (70)
Press Release (284813)
Multimedia
Podcasts (6)
Webinars (5)
Section
Business (101130)
Career Advice (1331)
Deals (18018)
Drug Delivery (24)
Drug Development (27563)
Employer Resources (70)
FDA (5242)
Job Trends (5772)
News (153001)
Policy (10741)
Tag
Academia (803)
Accelerated approval (3)
Adcomms (4)
Allergies (19)
Alliances (21966)
ALS (26)
Alzheimer's disease (398)
Antibody-drug conjugate (ADC) (40)
Approvals (5257)
Artificial intelligence (96)
Autoimmune disease (6)
Automation (5)
Bankruptcy (114)
Best Places to Work (4422)
BIOSECURE Act (4)
Biosimilars (28)
Biotechnology (60)
Bladder cancer (24)
Brain cancer (14)
Breast cancer (80)
Cancer (744)
Cardiovascular disease (41)
Career advice (1087)
Career pathing (16)
CAR-T (59)
Cell therapy (179)
Cervical cancer (5)
Clinical research (22610)
Collaboration (363)
Company closure (1)
Compensation (223)
Complete response letters (5)
COVID-19 (720)
CRISPR (22)
C-suite (150)
Cystic fibrosis (31)
Data (806)
Denatured (3)
Depression (13)
Diabetes (66)
Diagnostics (2965)
Digital health (4)
Diversity (1)
Diversity, equity & inclusion (18)
Drug discovery (39)
Drug pricing (21)
Drug shortages (2)
Duchenne muscular dystrophy (29)
Earnings (45425)
Editorial (7)
Employer branding (13)
Employer resources (63)
Events (47811)
Executive appointments (417)
FDA (5712)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (317)
Gene editing (44)
Generative AI (8)
Gene therapy (94)
GLP-1 (193)
Government (995)
Guidances (88)
Healthcare (7033)
Huntington's disease (5)
IgA nephropathy (9)
Immunology and inflammation (45)
Indications (8)
Infectious disease (757)
Inflammatory bowel disease (47)
Inflation Reduction Act (6)
Influenza (14)
Intellectual property (32)
Interviews (222)
IPO (9230)
IRA (10)
Job creations (1489)
Job search strategy (902)
Kidney cancer (9)
Labor market (16)
Layoffs (159)
Leadership (11)
Legal (2882)
Liver cancer (27)
Lung cancer (83)
Lymphoma (50)
Machine learning (2)
Management (22)
Manufacturing (100)
MASH (38)
Medical device (4968)
Medtech (4969)
Mergers & acquisitions (9086)
Metabolic disorders (196)
Multiple sclerosis (24)
NASH (7)
Neurodegenerative disease (28)
Neuropsychiatric disorders (6)
Neuroscience (573)
NextGen: Class of 2025 (2427)
Non-profit (1279)
Now hiring (9)
Obesity (85)
Opinion (83)
Ovarian cancer (31)
Pain (30)
Pancreatic cancer (23)
Parkinson's disease (38)
Partnered (8)
Patents (63)
Patient recruitment (42)
Peanut (10)
People (30575)
Pharmaceutical (12)
Pharmacy benefit managers (3)
Phase I (7089)
Phase II (9997)
Phase III (7638)
Pipeline (767)
Policy (33)
Postmarket research (808)
Preclinical (3006)
Press Release (66)
Prostate cancer (39)
Psychedelics (6)
Radiopharmaceuticals (124)
Rare diseases (126)
Real estate (2494)
Recruiting (29)
Regulatory (7489)
Reports (22)
Research institute (692)
Resumes & cover letters (289)
Rett syndrome (4)
RNA editing (2)
RSV (5)
Schizophrenia (33)
Series A (60)
Series B (36)
Service/supplier (3)
Sickle cell disease (13)
Special edition (7)
Spinal muscular atrophy (42)
Sponsored (10)
Startups (1664)
Stomach cancer (2)
Supply chain (17)
Tariffs (14)
The Weekly (3)
Vaccines (139)
Venture capitalists (13)
Weight loss (44)
Women's health (5)
Worklife (6)
Date
Last 7 days (457)
Last 30 days (1297)
Last 365 days (13514)
2025 (4998)
2024 (15102)
2023 (17914)
2022 (24445)
2021 (26169)
2020 (24324)
2019 (18361)
2018 (14216)
2017 (13653)
2016 (12694)
2015 (15693)
2014 (12213)
2013 (9908)
2012 (10816)
2011 (11385)
2010 (10889)
Location
Africa (314)
Alabama (17)
Alaska (5)
Arizona (83)
Arkansas (4)
Asia (15348)
Australia (2354)
California (3024)
Canada (985)
China (140)
Colorado (109)
Connecticut (142)
Delaware (43)
Europe (34587)
Florida (374)
Georgia (53)
Idaho (28)
Illinois (152)
India (13)
Indiana (104)
Iowa (4)
Japan (88)
Kansas (40)
Kentucky (11)
Louisiana (6)
Maine (42)
Maryland (313)
Massachusetts (2144)
Michigan (101)
Minnesota (175)
Mississippi (1)
Missouri (32)
Montana (17)
Nebraska (13)
Nevada (31)
New Hampshire (22)
New Jersey (761)
New Mexico (7)
New York (677)
North Carolina (466)
North Dakota (4)
Northern California (1353)
Ohio (98)
Oklahoma (7)
Oregon (11)
Pennsylvania (463)
Puerto Rico (1)
Rhode Island (17)
South America (418)
South Carolina (12)
Southern California (1177)
Tennessee (49)
Texas (339)
United States (10123)
Utah (71)
Virginia (64)
Washington D.C. (15)
Washington State (269)
West Virginia (3)
Wisconsin (33)
294,970 Results for "applied biosciences corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Spruce Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Updates
May 7, 2025
·
7 min read
Press Releases
Sagimet Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Updates
May 8, 2025
·
11 min read
Press Releases
Ventyx Biosciences Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Progress
May 9, 2025
·
11 min read
Press Releases
Aadi Bioscience to Report Fourth Quarter and Full-Year 2024 Results and Corporate Update
March 17, 2025
·
1 min read
Press Releases
Junshi Biosciences Announces 2024 Full Year Financial Results and Provides Corporate Updates
March 31, 2025
·
11 min read
Press Releases
Cellectar Biosciences Reports Financial Results for Year Ended 2024 and Provides a Corporate Update
March 13, 2025
·
11 min read
Complete response letters
Applied Therapeutics Crashes After FDA Rejection of Rare Disease Drug
After extending its review period to evaluate additional submissions, the FDA ultimately denied Applied Therapeutics’ govorestat for galactosemia, citing “deficiencies” with the application. The biotech plans to meet with the regulator to discuss the best way forward for the drug.
December 2, 2024
·
3 min read
·
Tristan Manalac
Press Releases
Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results
March 24, 2025
·
11 min read
Regulatory
FDA Warns Applied Therapeutics of ‘Objectionable Conditions’ in Govorestat Study
The agency’s warning letter outlines Applied Therapeutics’ failure to provide adequate information regarding the clinical trial—including a dosing error for govorestat—claims that the company said it had already addressed.
December 4, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Sagimet Biosciences Reports Full Year 2024 Financial Results and Provides Corporate Updates
March 12, 2025
·
12 min read
1 of 29,497
Next
